LEADING PHARMA Trademark

Trademark Overview


On Thursday, March 3, 2016, a trademark application was filed for LEADING PHARMA with the United States Patent and Trademark Office. The USPTO has given the LEADING PHARMA trademark a serial number of 86927234. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 19, 2022. This trademark is owned by Leading Pharma, LLC. The LEADING PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, heart disease, liver disease, kidney disease, digestive disorders, blood disorders, high blood pressure, depression, anxiety, and obesity; Vitamin and mineral supplements
leading pharma

General Information


Serial Number86927234
Word MarkLEADING PHARMA
Filing DateThursday, March 3, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 19, 2022
Registration Number5062963
Registration DateTuesday, October 18, 2016
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 2, 2016

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"
Description of MarkThe mark consists of the word "LEADING" in all capitalized letters where the "A" is missing its bar and beneath "LEADING" is the word "PHARMA" in smaller all capitalized letters.
Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, heart disease, liver disease, kidney disease, digestive disorders, blood disorders, high blood pressure, depression, anxiety, and obesity; Vitamin and mineral supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2016
Primary Code005
First Use Anywhere DateMonday, August 31, 2015
First Use In Commerce DateMonday, August 31, 2015

Trademark Owner History


Party NameLeading Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFairfield, NJ 07004

Party NameLeading Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFairfield, NJ 07004

Party NameLeading Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFairfield, NJ 07004

Trademark Events


Event DateEvent Description
Monday, March 7, 2016NEW APPLICATION ENTERED
Tuesday, March 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 16, 2016ASSIGNED TO EXAMINER
Thursday, June 16, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 16, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 23, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, June 23, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, June 23, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 23, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, June 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2016PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2016REGISTERED-PRINCIPAL REGISTER
Monday, October 18, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 29, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 12, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 19, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 19, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, October 18, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, November 12, 2025TEAS SECTION 8 & 9 RECEIVED